Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion

Size: px
Start display at page:

Download "Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion"

Transcription

1 Pediatric Diabetes 2007: 8: All rights reserved # 2007 The Authors Journal compilation # 2007 Blackwell Munksgaard Pediatric Diabetes Original Article Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion Patton SR, Dolan LM, Henry R, Powers SW. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion. Pediatric Diabetes 2007: 8: Background: The objective of this study was to examine the association between parental fear of hypoglycemia and average daily blood glucose control of young children with type 1 diabetes receiving continuous subcutaneous insulin infusion (CSII). We hypothesized that parental fear of hypoglycemia would correlate positively with children s average daily blood glucose control. Methods: Twenty-four families of children with type 1 diabetes who were receiving CSII were recruited from a pediatric hospital. Children had a mean age of yr (range 2 8 yr) and were evenly split on gender. Parents completed a modified version of the Hypoglycemia Fear Survey Parents of Young Children (HFS-PYC), a measure designed to assess fear and avoidance behaviors associated with hypoglycemia. Blood glucose was assessed for the 2 wk following completion of the HFS-PYC using a standard home blood glucose meter. Results: Parents of young children obtained a mean total HFS-PYC score of (possible range ), suggesting a moderate level of fear. The HFS-PYC was found to be internally consistent and had good test retest reliability. For parents of young children receiving CSII, fear of hypoglycemia correlated positively with children s mean daily blood glucose levels (r ¼ 0.41, p ¼ 0.05). Conclusions: Parents of young children with type 1 diabetes who are receiving CSII report significant fear of hypoglycemia. Parental fear of hypoglycemia may be a barrier to prevent optimal glycemic control. Susana R Patton a, Lawrence M Dolan b,c, Racquel Henry d and Scott W Powers c,d a Division of Child Behavioral Health, Department of Pediatrics and Communicable Diseases, C.S. Mott Children s Hospital and the University of Michigan, Ann Arbor, MI, USA; b Division of Endocrinology, Department of Pediatrics, Cincinnati Children s Hospital Medical Center, Cincinnati, OH, USA; c Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA; and d Division of Behavioral Medicine and Clinical Psychology, Department of Pediatrics, Cincinnati Children s Hospital Medical Center, Cincinnati, OH, USA Key words: assessment children hypoglycemia insulin pump Corresponding author: Susana R. Patton, PhD Division of Child Behavioral Health University of Michigan 1924 Taubman Center Box E Medical Center Drive Ann Arbor, MI USA. Tel: (734) ; fax: (734) ; susanap@med.umich.edu Submitted 15 November Accepted for publication 3 April 2007 Achieving optimal glycemic control is a fundamental goal of treatment in type 1 diabetes mellitus. Findings of the Diabetes Control and Complications Trial demonstrated that optimizing glycemic control can decrease the development and severity of microand macrovascular complications in adolescents and adults with type 1 diabetes (1, 2). Better glycemic control can be achieved through intensive insulin management delivered via multiple daily injections or 362 through the use of a continuous subcutaneous insulin infusion (CSII) pump. However, because early methods of intensive managements were associated with greater risk of hypoglycemia, intensive therapy was not initially recommended for all patients with type 1 diabetes. Recent improvements to intensive management, including advances in insulin pump technology and the use of insulin analogs, have decreased the risk of

2 hypoglycemia. Despite this, for young children with type 1 diabetes, movement to intensive management and, specifically, the use of a CSII pump has been controversial. For young children, the advantages of CSII are clear: greater flexibility with regards to the timing and amount of carbohydrates eaten, improved insulin management during times of high and low activity, ability to provide smaller doses of insulin, and a decrease in the number of insulin injections. Yet the possible increased risk of hypoglycemia is a striking disadvantage for this patient population, where frequent episodes of hypoglycemia could result in neurocognitive compromise (3). Recently, several small studies have demonstrated the safety of using CSII in young children with type 1 diabetes, despite the increased risk of hypoglycemia (4 7). These studies may help to make the use of CSII more widespread among families of young children with type 1 diabetes. While research is suggesting that CSII may be used safely in young children without significantly increasing their risk of hypoglycemia, no study has examined parents fear of hypoglycemia in this patient population or examined the relationship between parents fear of hypoglycemia and children s blood glucose levels. Fear of hypoglycemia has been well documented in adult and adolescent patients with type 1 diabetes, as well as in mothers of preadolescents with type 1 diabetes (8 11). Moreover, research suggests that patients who report fear of hypoglycemia may actively attempt to avoid hypoglycemia by maintaining higher than optimal blood glucose levels (10, 11). If parents of young children with type 1 diabetes who are receiving CSII therapy also fear hypoglycemic events, it is possible that this fear could affect how they manage their child s diabetes. Therefore, the objectives of this study were to assess the reliability of a modified form of the Hypoglycemia Fear Survey (HFS) in parents of young children receiving CSII and to examine the association between parents fear of hypoglycemia and children s average daily blood glucose control for a sample of young children receiving CSII. We anticipated that parents who report a high level of fear of hypoglycemia may be predisposed to maintain their children at higher than optimal blood glucose levels so as to avoid episodes of hypoglycemia. Thus, our primary hypothesis for this study was that in young children, parents fear of hypoglycemia would correlate positively with children s average daily blood glucose. Methods Participants Families who participated in this project were recruited from the Pediatric Diabetes Center (PDC) at Cincinnati Children s Hospital Medical Center (CCHMC). Families were eligible to participate if they had a child between 2 and 8 yr old who had a confirmed diagnosis of type 1 diabetes for at least 6 months and the family had at least 3 months experience using CSII. Based on these criteria, a preliminary list of 28 eligible families was obtained from the PDC and 24 consented to participate in the study, reflecting a recruitment rate of 86%. Families who elected not to participate reported concern with the extra time needed to complete the study as their primary reason for declining participation. No difference was found in the mean age of children of families that declined participation ( yr) when compared to children who participated ( yr). Procedure Families were contacted by a member of the research team via letter, telephone call, or in clinic solicitation. Families that agreed to participate scheduled an enrollment visit with the research team during which parents provided written informed consent, completed study questionnaires, and learned how to use a standardized home blood glucose meter (one participant used a compatible personal blood glucose meter). Approximately 2 wk after enrollment, families returned to the clinic for a follow-up study appointment, during which they completed one study questionnaire and data were downloaded from the home blood glucose meter. Families received a $20 gift card to Toys R Us for their participation and were allowed to keep the blood glucose meter they received for the study. This study was reviewed and approved by the CCHMC Institutional Review Board. Dependent measures Parents fear of hypoglycemia Children s average daily blood glucose levels. To measure children s average daily glycemic control, 23 families were given one FreeStyle (Abbott Laboratories, Abbott Park, IL, USA) home blood glucose meter to test their child s blood glucose during the study. One family elected to use a comparable but newer glucose meter (Flash, Abbott Laboratories), which they had recently received. Families were instructed to test their child s blood glucose via a finger stick at least four times daily for 2 wk using the study meter. In addition, families were asked to use the study meter for all blood glucose tests that were conducted away from home during the 2-wk period. Although all the families agreed to use the study meter exclusively for 2 wk, several families reported episodes of forgetting to bring the study meter with their child. In these situations, blood glucose levels that were not Pediatric Diabetes 2007: 8:

3 Patton et al. collected on the study meters were considered missing. While families were not given specific instructions regarding the timing of blood glucose tests, the majority of tests appeared to be preprandial and 21% of measures were gathered at nighttime (defined as between 21:00 and 05:30 hours). On average, children had blood glucose readings ( readings/d) for the study period. Children s average blood glucose control. To assess children s average blood glucose control, hemoglobin A1c (HbA1c) data were gathered from a medical chart review. For this study, children s HbA1c at the time of study enrollment and 3 months after study enrollment were collected. We elected to collect the HbA1c value from 3 months after study enrollment in order to capture children s average blood glucose levels at the time of study participation. Parents fear of hypoglycemia. Parents fear of hypoglycemia was assessed using a modified form of the Hypoglycemic Fear Survey Parent (HFS-P) (8, 9). The HFS-P is a valid 25-item questionnaire, which measures parent s fear of hypoglycemia in their children (9). The HFS-P is divided into two subscales, which independently assess parents behaviors related to preventing an episode of hypoglycemia and their worry that their child may experience an episode of hypoglycemia. For each item, parents are asked to report how often the item is true for them using a 5-point Likert scale (1 ¼ never to 5 ¼ very often). The HFS-P yields an individual subscale score for each of the Behavior and Worry scales and a Total Score, with higher scores indicating greater fear of hypoglycemia. For the current study, the HFS-P was modified to be specific to the issues of parents of young children with type 1 diabetes and named the Hypoglycemia Fear Survey Parents of Young Children (HFS-PYC). In addition, one question from the original HFS, which related to fear of having a hypoglycemic event while driving, was added to the HFS-PYC and was modified so that it described the parents fear that their child might have a low blood glucose while the parent was driving (8). Children s demographic information. Family demographics were obtained by parents self-report. Parents were asked to provide information about their child (e.g., gender, date of birth, ethnicity), themselves (e.g., relationship to the child, age, ethnicity), and their family (e.g., number of children, parents highest completed education level, and parents current employment). To estimate families socioeconomic status, parents level of education and current employment were recorded and analyzed using the Hollingshead Four-Factor Scale (A. Hollingshead, unpublished thesis). All other data were used to describe the sample. Children s medical history. Children s frequency of hypoglycemia was assessed via parent-report on a brief medical history form. In this form, parents were asked to self-report the age when their child was first diagnosed with type 1 diabetes. In addition, parents were asked to report on their child s frequency of hypoglycemic events within the past 6 months and if their child had experienced a seizure because of hypoglycemia. For this form, parents were to consider a hypoglycemic event to be any time their child had a blood glucose level of 60 mg/dl or less. Although many families define hypoglycemia based on symptoms, we decided not to use symptoms in our definition because the occurrence and severity of symptoms are very individual and may be difficult to measure reliably. Data analyses All data were analyzed using SPSS statistical software (2005 version). Sample characteristics and parents HFS-PYC scores were examined according to means, standard deviations, and frequencies. To assess the reliability of the HFS-PYC, data on the internal consistency and test retest reliability were obtained. To test the primary hypothesis that parents fear of hypoglycemia would correlate positively with children s average daily blood glucose levels, two-tailed Pearson product moment correlations were used. Two-tailed Pearson correlations were also used to explore associations between parents HFS-PYC scores and descriptive data (e.g., child age, length of time with type 1 diabetes). However, because these correlations were considered exploratory and were completed after examining the primary associations, we elected not to correct for multiple correlations. Post hoc correlations suggested no relationships between children s average daily blood glucose and their age and disease duration. Finally, to aid in interpreting the findings of this study, the authors compared fear of hypoglycemia in parents of young children with type 1 diabetes to HFS scores from a published study of mothers of older children with type 1 diabetes (9). To conduct these analyses, each score was first divided by the number of items in the scale to obtain an adjusted score that controlled for differences in the number of questionnaire items (e.g., 25 items in the published sample and 26 items in the current sample). The adjusted scores were then compared using a series of one-sample t-tests. Results Participants Table 1 presents descriptive statistics and clinical data for the 24 children who participated in this study. Children had a mean age of yr and a mean time since diagnosis of yr. There were Pediatric Diabetes 2007: 8:

4 Table 1. Demographic and health information Variable M SD Age (yr) Blood glucose level (mg/dl) HbA1c (at study enrollment) HbA1c (3 months post-study enrollment) BMI z-bmi Frequency % Gender Boy Girl Race White Non-White 1 4 Parent respondent Mother Father 4 17 Socioeconomic status* I 0 0 II 1 4 III 7 29 IV V 4 17 Marital status Married Frequency of hypoglycemia (,60 mg/dl) Once per day /wk /wk Once per month 2 9 Once every few months 1 4 History of hypoglycemic seizure Yes 6 25 No HbA1c at study enrollment. BMI, body mass index; HbA1c, hemoglobin A1c; M, mean; SD, standard deviation. *The Hollingshead Four-Factor Scale is measured from I (lowest level) to V (highest level). boys and 12 girls in the sample. Children in this sample had a mean daily blood glucose level of mg/dl. The target blood glucose range for children in this sample was between 70 and 200 mg/dl. Overall, children averaged 51 13% of blood glucose tests within the target range, 5 3% of tests below the target range, and 44 14% above the target range. Children had a mean HbA1c of at study enrollment and after 3 months of study enrollment (reference range %). Children s HbA1c levels 3 months after study enrollment correlated with their average number of blood glucose tests performed each day during the 2-wk study period (r ¼ 20.49, p, 0.05), while a statistical trend was found when correlating children s HbA1c levels with their average blood glucose levels for the study (r ¼ 0.38, p ¼ 0.07). Children s HbA1c levels 3 months after study enrollment correlated with the percentage of blood glucose tests that were within the target range (r ¼ 20.49, p, 0.05). With respect to fear of hypoglycemia, parents obtained a mean Total Score on the HFS-PYC of (possible range ). Parents mean Worry and Behavior subscale scores were (possible range 16 80) and (possible range 10 50), respectively. Parents HFS-PYC scores did not correlate with children s age, time since diagnosis, or average number of blood glucose tests performed each day. Interestingly, negative associations were found between families level of socioeconomic status and parents Total and Worry Scores of the HFS-PYC (r ¼ 20.52, p, 0.01, and r ¼ 20.47, p, 0.05). While parents Total Scores on the HFS-PYC were not related to their reporting of how frequently their child experienced a hypoglycemic event, among children who had had a hypoglycemic seizure, comparisons revealed a statistical trend in parents HFS-PYC Worry Scores, suggesting that parents of young children who have had seizures may worry more about hypoglycemia than parents of children who have not had a seizure ( and , respectively). With respect to children s HbA1c, only parents HFS-PYC Behavior Score was found to correlate (r ¼ 0.42, p ¼ 0.04) with children s HbA1c 3 months after study enrollment, suggesting that parents of children with higher average blood glucose levels endorsed frequent use of behaviors aimed at preventing hypoglycemia. Table 2 identifies specific items on the HFS-PYC that were endorsed by parents as common strategies they might use to avoid hypoglycemia or frequent worries about hypoglycemia. The most common strategies endorsed by parents to prevent hypoglycemia were Ôcarrying fast-acting sugar (100%), Ôchecking blood sugar often when attending a long event (75%), Ôavoiding being away from the child when his/her sugar might go low (67%), and Ôfeeding the child at the first signs of hypoglycemia (63%). The most common worries reported by parents specific to hypoglycemia were Ôfeeling the child will have a low blood sugar while asleep (63%) and Ôthe child having a low blood sugar when away from the parent (46%). Reliability Parents fear of hypoglycemia Internal consistency of the HFS-PYC was calculated using Cronbach s alpha coefficient for the Total scale and each subscale. Results found alpha coefficients of 0.86, 0.62, and 0.89 for the HFS-PYC Total, Behavior, and Worry Scores, respectively, suggesting that the measure retained good internal consistency. The 2-wk test retest reliability of the HFS-PYC was 0.91 (p, 0.001), 0.73 (p, 0.001), and 0.91 (p, 0.001) for the Total, Behavior, and Worry Scores, respectively, indicating good stability of scores for the HFS-PYC. Pediatric Diabetes 2007: 8:

5 Patton et al. Associations between parents fear of hypoglycemia and Children s average daily blood glucose levels Next, analyses sought to examine associations between parents fear of hypoglycemia and children s average daily blood glucose levels. Our primary analyses sought to correlate children s average daily blood glucose levels with parents HFS-PYC scores, while secondary analyses examined associations between parents HFS-PYC scores and the percentage of blood glucose tests that were within, below, and above the target range. Consistent with our hypothesis, findings revealed a significant positive association between parents Total HFS-PYC scores and children s average daily blood glucose control (r ¼ 0.41, p ¼ 0.05), suggesting that among parents of young children receiving CSII, parents of children with higher average blood glucose levels reported greater fear of hypoglycemia. Furthermore, a statistical trend was found between parents Worry Score and children s daily blood glucose control (r ¼ 0.39, p ¼ 0.06). While parents reporting on the Behavior scale of the HFS- PYC did correlate with children s HbA1c levels for blood glucose values associated with the time of the study, no correlation was found between parents HFS- PYC Behavior Scores and children s average daily blood glucose levels. When data were examined according to the percentage of blood glucose tests that were within, below, or above the target range of mg/dl, generally similar findings were obtained. Parents HFS-PYC scores correlated negatively with the percentage of tests within the target range (Total: r ¼ 20.54, p, 0.05; Worry: r ¼ 20.47, p, 0.05; and Behavior: r ¼ 20.43, p, 0.05) and positively with the percentage of tests above the target range (Total: r ¼ 0.54, p, 0.05; Worry: r ¼ 0.45, p, 0.05; and Behavior: r ¼ 0.47, p, 0.05). There were no significant correlations between parents HFS-PYC scores and the percentage of blood glucose tests that were below the target range. One-sample comparisons of parents HFS scores Finally, analyses sought to compare fear of hypoglycemia for parents of young children with type 1 diabetes to mothers of school-age children with type 1 diabetes using adjusted HFS scores (9). Findings revealed no difference in the adjusted Total Scores of the HFS for parents of young children ( ) and mothers of school-age children ( ). Likewise, no differences were found in the adjusted Behavior ( and , parents of young children and mothers of school-age children, respectively) and Worry ( and , parents of young children and mothers of school-age children, respectively) Scores. Discussion Current research suggests that CSII therapy can be used safely in young children with type 1 diabetes, despite the increased risk of hypoglycemia found in early studies conducted before the widespread use of insulin analogs (4 7). However, because of the risk of neurocognitive compromise related to frequent episodes of hypoglycemia in young children, many parents may still be concerned about using this technology (3). No study has specifically examined parents fear of hypoglycemia in young children with type 1 diabetes who are receiving CSII therapy. In this study, the HFS-PYC overall demonstrated good internal consistency and test retest reliability in parents of young children receiving CSII. The Behavior subscale of the HFS-PYC had the lowest measure of internal consistency and test retest reliability, which was likely because of a difference in the number of items for this subscale (e.g., 10 vs. 16 items) and lack of variability in parent reporting. The results from this cross-sectional study of parents fear of hypoglycemia in families of young children receiving CSII therapy found that fear of hypoglycemia is a frequent concern for these families and may be highest among parents of children with higher average blood glucose levels vs. lower levels. No differences were found when comparing fear of hypoglycemia in parents of young children and mothers of school-age children with type 1 diabetes (9). Consistent with the literature, parents fear was not associated with child demographic variables, such as age, time since diagnosis, number of blood glucose tests performed per day, or HbA1c levels (9). There was also no association between parents fear of hypoglycemia and the number of hypoglycemic episodes reported by parents (9). In contrast to previous research, the current study found a negative association between parents fear of hypoglycemia and families socioeconomic level, suggesting that higher socioeconomic status may protect parents from greater levels of fear of hypoglycemia. The current study also found a positive association between parents HFS-PYC Behavior Scores and children s HbA1c levels, suggesting that parents of young children receiving CSII may voluntarily engage in diabetes management behaviors that prevent hypoglycemia and elevate children s blood glucose levels. Indeed, item-level analysis of the HFS-PYC suggested that parents may frequently feed their child if they feel their child s blood glucose is getting low. These analyses also suggested that parents may be vigilant about hypoglycemia and test their child s blood glucose often or avoid being away from their child if there is a concern that his/her blood glucose could drop. However, because children s HbA1c levels were collected for the 3 months subsequent to study enrollment, it is possible that 366 Pediatric Diabetes 2007: 8:

6 Parents fear of hypoglycemia Table 2. Items of the HFS-PYC endorsed by parents as occurring Ôoften or Ôvery often HFS-PYC items % Endorsed Behavior scale 1. Feed my child large snacks at bedtime Avoid allowing my child to be away from me when his/her 67 sugar is likely to be low 3. Try to run a little high to be on the safe side Keep my child s sugar higher when he/she will be away from me Feed my child as soon as I feel or see the first signs of low blood sugar Reduce my child s insulin when I think his/her blood sugar is low Keep my child s blood sugar higher when I know he/she is planning 29 to be at a long event (e.g., school, party) 8. Always carry fast-acting sugar Don t allow my child to play excessively when I think his/her blood sugar is low Check my child s blood sugar often when he/she is planning to be at 75 a long event (e.g., school, party) Worry scale 11. Not recognizing that my child is having a hypoglycemic event Not having food or fruit juice with me for my child Having my child dizzy or pass out in public Feeling that my child will have a low blood sugar while he/she is asleep My child embarrassing him/herself in front of friends/family in a social situation My child having a low blood sugar when he/she is away from me My child being disoriented My child losing control No one being around to help my child during a hypoglycemic event My child making a mistake or having an accident at day care/school My child getting a bad evaluation at day care/school because of 25 something that happens when his/her sugar is low 22. My child having seizures My child developing long-term complications from frequent low blood sugars My child feeling light headed or faint My child having an insulin reaction My child having a hypoglycemic event while I m driving 25 HFS-PYC, Hypoglycemia Fear Survey Parents of Young Children. parents completion of the HFS-PYC may have sensitized them to episodes of low blood glucose and affected how they manage their child s diabetes. Thus, the reader is cautioned against overinterpreting this relationship. This is the first study to examine parents fear of hypoglycemia in young children (less than 8 yr old) with type 1 diabetes who are exclusively managed via CSII therapy. In young children, parents assume the full burden of caring for their child s diabetes. This job is complicated by normal developmental limitations of this age range, including limited cognitive insight into physical symptoms, limited language skills, and increasing independence seeking and behavioral resistance (12). Moreover, because young children with type 1 diabetes are frequently more insulin sensitive than older children, parents of young children are frequently advised to be vigilant with respect to monitoring their child s diet and behavior and checking their child s blood glucose levels (13). As a result, the vigilance needed for parents to maintain their young children in optimal glycemic control may contribute to parents heightened fear of hypoglycemia. While some level of fear of hypoglycemia is adaptive and could help parents to protect their children from hypoglycemic episodes, higher levels of fear may lead to poorer coping strategies, such as administering lower doses of insulin, feeding children without administering insulin, or overtreating episodes of low blood glucose levels. These behaviors, in turn, may lead to higher than optimal blood glucose levels. Recent research suggests that prolonged and frequent episodes of hyperglycemia may also be associated with neurocognitive compromise in young children (14), which underscores the importance of teaching families to maintain their children s blood glucose levels close to the normal range. It is also possible that parents who have greater fear of hypoglycemia may regularly overfeed their children, which could over time lead to weight gain and greater insulin resistance. To achieve the best possible control, families using CSII are required to adhere to the insulin prescriptions and target blood glucose ranges suggested by their health care provider. Thus, in situations where children have higher than optimal blood glucose levels and/or parents report feeding their child frequent snacks or large meals, health care providers should assess parents fear of hypoglycemia Pediatric Diabetes 2007: 8:

7 Patton et al. and help parents use more adaptive strategies for coping with their fear and managing their child s diabetes. Scheduled self-monitoring of children s blood glucose levels and recording of these levels in a log book is one adaptive strategy that parents could be taught to use to manage their child s diabetes and their fear, as this strategy could lead to both accurate measurement of children s blood glucose levels as well as identification of patterns of behavior that may precipitate low blood glucose episodes. Similarly, in situations where parents are overfeeding their child, they may benefit from counseling by registered dietician and development of an individualized meal plan with specific carbohydrate targets for meals and snacks. In this study, we report on parents fear of hypoglycemia in young children with type 1 diabetes who are receiving CSII. It should be noted that the data were obtained from a relatively small sample of families of young children with type 1 diabetes who were primarily White, married, and from the middle to upper middle class. While the sample of families recruited for this study is representative of the clinic population and the communities from which it was drawn, our results may not generalize to patient samples drawn from a diverse population. In addition, our study used a parent-report questionnaire to measure parents fear of hypoglycemia. While the HFS-PYC and the original HFS-P have demonstrated acceptable reliability (9), self-report measures are vulnerable to a reporting bias. Therefore, caution is advised in the interpretation and application of these findings, as it is possible that parents reporting on the HFS-PYC could have been influenced by elements of social desirability. For parents of young children with type 1 diabetes who are receiving CSII therapy, fear of hypoglycemia appears to be a significant source of concern and may predict poorer blood glucose control for many children. While it is important that parents understand the seriousness of hypoglycemia and the need to avoid hypoglycemic episodes, if their fear is too great, parents could begin to use more maladaptive strategies for managing their anxiety, which ultimately could affect children s long-term health outcomes. The findings of this study suggest that health care providers may need to assess for fear of hypoglycemia in parents of young children receiving CSII. Use of the HFS-PYC could be incorporated into the clinical care regimen to assess and prompt discussion of this topic. The measure takes less than 10 min to complete and can be readily scored within a clinical context. Future research should replicate our findings regarding the reliability and usefulness of the HFS-PYC. Also, studies are needed that focus on developing interventions to help parents of young children with type 1 diabetes learn to deal effectively with hypoglycemic events and address parents fear of hypoglycemia. Acknowledgements This research was supported in part by grants R01-DK54915 and K24-DK59973 (to S. W. P.) and grant F32-DK61121 (to S. R. P.) from the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases. We thank TheraSense (now Abbott Laboratories) for their donation of FreeStyle blood glucose meters, software, and testing supplies. References 1. THE DIABETES CONTROL AND COMPLICATIONS TRIAL. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993: 329: THE DIABETES CONTROL AND COMPLICATIONS TRIAL. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr 1994: 125: DESROCHER M, ROVET J. Neurocognitive correlates of type 1 diabetes mellitus in childhood. Neuropsychol Dev Cogn Sect C Child Neuropsychol 2004: 10: DIMEGLIO LA, POTTORFF TM, BOYD SR, FRANCE L, FINEBERG N, EUGSTER EA. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004: 145: FOX LA, BUCKLOH LM, SMITH SD, WYSOCKI T, MAURAS N. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005: 28: WEINZIMER SA, AHERN JH, DOYLE EA et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004: 114: JEHA GS, KARAVITI LP, ANDERSON B et al. Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia. Diabetes Technol Ther 2005: 7: COX DJ, IRVINE A, GONDER-FREDERICK L, NOWACEK G, BUTTERFIELD J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 1987: 10: CLARKE WL, GONDER-FREDERICK A, SNYDER AL, COX DJ. Maternal fear of hypoglycemia in their children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab 1998: 11 (Suppl. 1): IRVINE AA, COX D, GONDER-FREDERICK L. Fear of hypoglycemia: relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus. Health Psychol 1992: 11: IRVINE AA, COX D, GONDER-FREDERICK L. The fear of hypoglycaemia scale. In: Bradley C, ed. The Handbook of Psychology and Diabetes. UK: Harwood Academic Publishers, 1994: LINSCHEID T, BUDD K, RASNAKE L. Pediatric feeding disorders. In: Roberts M, ed. Handbook of Pediatric Psychology. New York: The Guilford Press; 2003: GOLDEN MP, RUSSELL BP, INGERSOLL GM, GRAY DL, HUMMER KM. Management of diabetes mellitus in children younger than 5 years of age. Am J Dis Child 1985: 139: RYAN C, GURTUNCA N, BECKER D. Hypoglycemia: a complication of diabetes therapy in children. Pediatr Clin North Am 2005: 52: Pediatric Diabetes 2007: 8:

Original Article. Pediatric Diabetes

Original Article. Pediatric Diabetes Pediatric Diabetes 2009: 10: 455 460 doi: 10.1111/j.1399-5448.2009.00506.x All rights reserved # 2009 The Authors Journal compilation # 2009 Blackwell Munksgaard Pediatric Diabetes Original Article Feeding

More information

Development of a New Fear of Hypoglycemia Scale: Preliminary Results

Development of a New Fear of Hypoglycemia Scale: Preliminary Results Development of a New Fear of Hypoglycemia Scale: Preliminary Results Jodi L. Kamps, 1 PHD, Michael C. Roberts, 2 PHD, ABPP, and R. Enrique Varela, 3 PHD 1 Children s Hospital of New Orleans, 2 University

More information

Mealtime Interactions Relate to Dietary Adherence and Glycemic Control in Young Children With Type 1 Diabetes

Mealtime Interactions Relate to Dietary Adherence and Glycemic Control in Young Children With Type 1 Diabetes Epidemiology/Heatlh Services/Psychosocial Research O R I G I N A L A R T I C L E Mealtime Interactions Relate to Dietary Adherence and Glycemic Control in Young Children With Type 1 Diabetes SUSANA R.

More information

No disclosures 8/4/2017. Cari Berget RN, MPH, CDE Clinical Research Nurse, Diabetes Educator. Disclosure to Participants

No disclosures 8/4/2017. Cari Berget RN, MPH, CDE Clinical Research Nurse, Diabetes Educator. Disclosure to Participants Cari Berget RN, MPH, CDE Clinical Research Nurse, Diabetes Educator Barbara Davis Center for Diabetes Aurora, CO Disclosure to Participants No disclosures FEAR OF HYPOGLYCEMIA AND IMPLICATIONS FOR CLINICAL

More information

Family functioning at meals relates to adherence in young children with type 1 diabetesjpc_

Family functioning at meals relates to adherence in young children with type 1 diabetesjpc_ doi:10.1111/j.1440-1754.2009.01604.x ORIGINAL ARTICLE Family functioning at meals relates to adherence in young children with type 1 diabetesjpc_1604 736..741 Susana R Patton, 1 Carrie Piazza-Waggoner,

More information

CLINICAL UTILITY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN PATIENTS WITH TYPE 1 DIABETES: A MACEDONIAN REPORT

CLINICAL UTILITY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN PATIENTS WITH TYPE 1 DIABETES: A MACEDONIAN REPORT University Department of Endocrinology, Diabetes and Metabolic Disorders, Medical Faculty, Sv. Kiril I Metodij University, Skopje, Macedonia Scientific Paper Received: February 19, 2007 Accepted: March

More information

Blood Glucose Awareness Training (BGAT-2)

Blood Glucose Awareness Training (BGAT-2) Clinical Care/Education/Nutrition O R I G I N A L A R T I C L E Blood Glucose Awareness Training (BGAT-2) Long-term benefits DANIEL J. COX, PHD 1 LINDA GONDER-FREDERICK, PHD 1 WILLIAM POLOKY, PHD 2 3 DAVID

More information

With acknowledgments to Dr. Michael Vallis and the Behaviour Change Institute

With acknowledgments to Dr. Michael Vallis and the Behaviour Change Institute Katie Birnie, Psychology Resident, IWK Health Centre Dr. Elizabeth McLaughlin, Pediatric Health Psychology Service, IWK Health Centre Karen O Brien, Health Psychology Resident, QEII With acknowledgments

More information

Subheadings adapted to the terminology in the respective databases were included in the searches.

Subheadings adapted to the terminology in the respective databases were included in the searches. Table 1. Literature searches related to the literature review (Chapter 2) * Search terms ** Diabetes Mellitus, Type 1 OR type 1 diabetes + parent OR parenting + hypoglycemia + fear Diabetes Mellitus, Type

More information

Updates in Diabetes Technology

Updates in Diabetes Technology Updates in Diabetes Technology Jessica Kirk, MSN, RN, CPN, CDE Nurse Manager, Endo ECHO No disclosures Disclosures 1 Objectives Distinguish patients appropriate for continuous glucose monitoring and insulin

More information

UTILIZING ACTIGRAPHY TO EXAMINE SLEEP IN YOUNG CHILDREN WITH TYPE 1 DIABETES

UTILIZING ACTIGRAPHY TO EXAMINE SLEEP IN YOUNG CHILDREN WITH TYPE 1 DIABETES UTILIZING ACTIGRAPHY TO EXAMINE SLEEP IN YOUNG CHILDREN WITH TYPE 1 DIABETES Jadienne Lord, B.A. Beth Malow, M.D. Sarah Jaser, Ph.D. Vanderbilt University Medical Center Ian M. Burr Division of Pediatric

More information

Research Article Measures of Adherence and Challenges in Using Glucometer Data in Youth with Type 1 Diabetes: Rethinking the Value of Self-Report

Research Article Measures of Adherence and Challenges in Using Glucometer Data in Youth with Type 1 Diabetes: Rethinking the Value of Self-Report Hindawi Diabetes Research Volume 2017, Article ID 1075428, 4 pages https://doi.org/10.1155/2017/1075428 Research Article Measures of Adherence and Challenges in Using Glucometer Data in Youth with Type

More information

Diabetes Care 34: , 2011

Diabetes Care 34: , 2011 Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Psychometric Properties of the Hypoglycemia Fear Survey-II for Adults With Type 1 Diabetes LINDA A. GONDER-FREDERICK,

More information

LOW SUGAR: CAUSES, COMPLICATIONS AND MANAGEMENT OF HYPOGLYCEMIA

LOW SUGAR: CAUSES, COMPLICATIONS AND MANAGEMENT OF HYPOGLYCEMIA LOW SUGAR: CAUSES, COMPLICATIONS AND MANAGEMENT OF HYPOGLYCEMIA Anne Leake, PhD, APRN-Rx, BC-ADM ECHO Diabetes Learning Group 3/28/2018 Objectives 1. Identify common preventable causes of hypoglycemia

More information

Diabetes Management with Continuous Glucose Monitoring & Multiple Daily Injections. Aaron Michels MD

Diabetes Management with Continuous Glucose Monitoring & Multiple Daily Injections. Aaron Michels MD Diabetes Management with Continuous Glucose Monitoring & Multiple Daily Injections Aaron Michels MD Outline SMBG & CGM by age group JDRF CGM Trial Sensor Augmented Insulin Pump Therapy for A1c Reduction

More information

Fear of hypoglycemia, parenting stress, and metabolic control for children with type 1 diabetes and their parents

Fear of hypoglycemia, parenting stress, and metabolic control for children with type 1 diabetes and their parents The final publication is available at Springer via http://dx.doi.org/10.1007/s10880-017-9489-8 Fear of hypoglycemia, parenting stress, and metabolic control for children with type 1 diabetes and their

More information

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Goulburn Region Preschool Association Inc.

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Goulburn Region Preschool Association Inc. DIABETES POLICY Mandatory Quality Area 2 The content of this policy was developed for KPV by advocacy and diabetes educators at Diabetes Australia Vic and the Royal Children s Hospital Melbourne s manager

More information

Barriers to physical activity among patients with type 1 diabetes

Barriers to physical activity among patients with type 1 diabetes Diabetes Care Publish Ahead of Print, published online August 8, 2008 Barriers to physical activity in type 1 diabetes Barriers to physical activity among patients with type 1 diabetes Anne-Sophie Brazeau

More information

Laura Smith University of Cincinnati. June 7 th, 2012

Laura Smith University of Cincinnati. June 7 th, 2012 Laura Smith University of Cincinnati June 7 th, 2012 1. Background 2. Grant 3. Research Strategy Background Practical /Relevant Useful skill Filled a need 25.8 million in the U.S. (2011) A leading cause

More information

5. Diabetes Education

5. Diabetes Education 5. iabetes Education 5.1. Structured education aimed at families and/or patients with diabetes mellitus Key question: Are structured educational programs aimed at people with diabetes mellitus type 1 and

More information

Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)

Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57) Audit support for continuous subcutaneous insulin (review of technology appraisal guidance 57) Issue date: 2008 Audit support Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus

More information

Advanced Pharmacology Diabetes Homework

Advanced Pharmacology Diabetes Homework Advanced Pharmacology Diabetes Homework Points: 25 Comments: Name: Tracy Hill WU ID #: 20015608 E-mail: tracy.hill@washburn.edu _TH I hereby certify that the work submitted is my own, and that I have not

More information

These results are supplied for informational purposes only.

These results are supplied for informational purposes only. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov

More information

DIAGNOSIS OF DIABETES NOW WHAT?

DIAGNOSIS OF DIABETES NOW WHAT? DIAGNOSIS OF DIABETES NOW WHAT? DISCUSS GOALS FOR DIABETES CARE IDENTIFY COMMON COMPLIANCE- ADHERENCE ISSUES DESCRIBE TECHNOLOGY TO ASSIST AND / OR IMPROVE DIABETES CARE WHAT DO WE WANT OUR PATIENTS TO

More information

THE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018.

THE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018. THE SHEFFIELD AREA PRESCRIBING GROUP Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes Date: March 2018 Overview Freestyle Libre is a flash glucose sensor device that measures *interstitial

More information

Type 1 Diabetes - Pediatrics

Type 1 Diabetes - Pediatrics Type 1 Diabetes - Pediatrics Introduction Type 1 diabetes prevents the body from removing sugar from the blood stream normally. Diabetes can lead to serious health problems if it is not treated. Currently

More information

Diabetes Care Publish Ahead of Print, published online December 20, 2007

Diabetes Care Publish Ahead of Print, published online December 20, 2007 Diabetes Care Publish Ahead of Print, published online December 20, 2007 FreeStyle Navigator Continuous Glucose Monitoring System Use in Children with Type 1 Diabetes using glargine-based multiple daily

More information

PARENT PACKET - DIABETES

PARENT PACKET - DIABETES School Year: Lexington-Fayette County Health Department SCHOOL HEALTH DIVISION 650 Newtown Pike Lexington, Kentucky 40508-1197 (859) 288-2314 (859) 288-2313 Fax PARENT PACKET - DIABETES Dear Parent/Guardian:

More information

Figure 2.1: Glucose meter

Figure 2.1: Glucose meter CHAPTER TWO: MONITORING TECHNOLOGIES 2.1 Introduction Glucose monitoring is a method of self-testing glucose (blood sugar) levels for the management of diabetes. Traditionally, it involves pricking the

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 57 Effective Health Care Program Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness Executive Summary Background Diabetes mellitus is

More information

VIDEO WORKSHEET. Review: # Name: Hour: After viewing each segment, answer the following questions. Making Family Meals Happen

VIDEO WORKSHEET. Review: # Name: Hour: After viewing each segment, answer the following questions. Making Family Meals Happen #300008 Name: Hour: VIDEO WORKSHEET Review: After viewing each segment, answer the following questions. Making Family Meals Happen 1. What is one of the most important keys to feeding well? 2. Children

More information

Current Glucometers. Junior s s Glucose Log. All have advantages and disadvantages Answer 2

Current Glucometers. Junior s s Glucose Log. All have advantages and disadvantages Answer 2 Diabetes Dilemmas: Using Technology To Solve Clinical Conundrums Stephen E. Gitelman, MD UCSF A teenager with type 1 diabetes for 5 years comes into your office for a follow- up visit. You want to review

More information

Insulin Pump Therapy in children. Prof. Abdulmoein Al-Agha, FRCPCH(UK)

Insulin Pump Therapy in children. Prof. Abdulmoein Al-Agha, FRCPCH(UK) Insulin Pump Therapy in children Prof. Abdulmoein Al-Agha, FRCPCH(UK) aagha@kau.edu.sa Highlights Evolution of insulin pump Pumps mimics Pancreas Goals of diabetes care What lowers HbA1c Criteria for selection

More information

Supplemental Health Record and Authorization for Care of Child with Insulin Dependent Diabetes

Supplemental Health Record and Authorization for Care of Child with Insulin Dependent Diabetes 477 Beaverkill Road Olivebridge, New York 12461 (845) 657-8333 Ext. 15 Fax (845) 657-8489 martin.bernstein@ashokancenter.org www.ashokancenter.org 2012-13 Supplemental Health Record and Authorization for

More information

Monitoring Your Diabetes. Diabetes Monitoring

Monitoring Your Diabetes. Diabetes Monitoring Monitoring Your Diabetes If you have Diabetes, you should be checking your blood glucose at home on a daily basis. But this daily testing does not show your sugar levels over a longer period of time. That

More information

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Outline of Material Introduction

More information

INSULIN THERAY دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد

INSULIN THERAY دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد INSULIN THERAY DIABETES1 IN TYPE دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد Goals of management Manage symptoms Prevent acute and late complications Improve quality of life Avoid

More information

Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES

Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES Many parents whose child is diagnosed with Type 1 diabetes wonder: Why is this happening to my child?

More information

Chapter 3 - Does Low Well-being Modify the Effects of

Chapter 3 - Does Low Well-being Modify the Effects of Chapter 3 - Does Low Well-being Modify the Effects of PRISMA (Dutch DESMOND), a Structured Selfmanagement-education Program for People with Type 2 Diabetes? Published as: van Vugt M, de Wit M, Bader S,

More information

Effects of Diabetes on Learning in Children

Effects of Diabetes on Learning in Children Effects of Diabetes on Learning in Children Ann Marie McCarthy, PhD, RN, PNP*; Scott Lindgren, PhD ; Michelle A. Mengeling, MS ; Eva Tsalikian MD ; and Janet C. Engvall, MSN, RN* ABSTRACT. Objective. Subtle

More information

Improvement and Emergence of Insulin Restriction in Women With Type 1 Diabetes

Improvement and Emergence of Insulin Restriction in Women With Type 1 Diabetes Improvement and Emergence of Insulin Restriction in Women With Type 1 Diabetes The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.

More information

Chapter 11 summary definitief ineke brands.indd :57:59

Chapter 11 summary definitief ineke brands.indd :57:59 chapter 11 Summary chapter 11 Both type 1 and type 2 diabetes mellitus are associated with altered brain function, a complication referred to as diabetic encephalopathy. Previous studies have shown that

More information

Switching from insulin glargine to insulin degludec: Safety and efficacy in Colombian adolescents with type 1 diabetes

Switching from insulin glargine to insulin degludec: Safety and efficacy in Colombian adolescents with type 1 diabetes Diabetes Management Switching from insulin glargine to insulin degludec: Safety and efficacy in Colombian adolescents with type 1 diabetes Myrey Siuffi D* ABSTRACT Introduction: Degludec (Ideg) is an ultra-long

More information

FLIPS FreeStyle Libre in Pregnancy Study

FLIPS FreeStyle Libre in Pregnancy Study FLIPS FreeStyle Libre in Pregnancy Study Evaluation of the Accuracy of the FreeStyle Libre Flash Glucose Monitoring System Use in Pregnancy Label Extension Study (CE) Section 1: PARTICIPANT INFORMATION

More information

As of 2007, approximately 23.6 million

As of 2007, approximately 23.6 million P O S I T I O N S T A T E M E N T Diabetes and Employment AMERICAN DIABETES ASSOCIATION As of 2007, approximately 23.6 million Americans have diabetes (1), most of whom are or wish to be participating

More information

Training for Unlicensed Diabetes Care Assistants Pre and Post Test. Name: Date:

Training for Unlicensed Diabetes Care Assistants Pre and Post Test. Name: Date: Training for Unlicensed Diabetes Care Assistants Pre and Post Test Name: Date: To check your understanding about how to assist students with diabetes in school, the following questions are about imaginary

More information

Report Reference Guide

Report Reference Guide Report Reference Guide How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used to generate the sample reports was from sample patient

More information

Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond)

Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) 9501366-011 20110401 Objectives Understand the need for insulin pumps and CGMS in managing

More information

CareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes

CareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes CareLink Management Software for Diabetes software REPORT REFERENCE GUIDE How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used

More information

Hypoglycemia. When recognized early, hypoglycemia can be treated successfully.

Hypoglycemia. When recognized early, hypoglycemia can be treated successfully. Hypoglycemia Introduction Hypoglycemia is a condition that causes blood sugar level to drop dangerously low. It mostly shows up in diabetic patients who take insulin. When recognized early, hypoglycemia

More information

Module 5. Understanding Insulin Therapy

Module 5. Understanding Insulin Therapy Module 5. Understanding Insulin Therapy EDUCATIONAL OBJECTIVES Upon completion of this activity, participants will be better able to: 1. Define the basic physiologic concept of basal-bolus insulin; 2.

More information

Subjects are requested to perform self-monitoring of blood glucose (SMBG) 4 times per

Subjects are requested to perform self-monitoring of blood glucose (SMBG) 4 times per APPENDIX 1 Insulin Titration Algorithm Subjects are requested to perform self-monitoring of blood glucose (SMBG) 4 times per day. All subjects will be contacted weekly to review hypoglycemia and adverse

More information

Standards of Care for Students with Type 1 Diabetes in School

Standards of Care for Students with Type 1 Diabetes in School Standards of Care for Students with Type 1 Diabetes in School Purpose: To acknowledge and clarify the essential partnerships among parents or caregivers, students and school personnel in the care of students

More information

REPORT INTERPRETATION

REPORT INTERPRETATION REPORT INTERPRETATION: Interpreting ipro Professional Continuous Glucose Monitoring (CGM) Reports and Making Therapy Adjustments TARGET AUDIENCE The audience for this section is physicians, mid-level practitioners,

More information

People living with type 1 diabetes face a. Barriers to improving glycaemic control in CSII. Joan Everett, Anita Bowes, David Kerr

People living with type 1 diabetes face a. Barriers to improving glycaemic control in CSII. Joan Everett, Anita Bowes, David Kerr Barriers to improving glycaemic control in CSII Article points 1. Focus groups were conducted to determine why some people with type 1 diabetes using continuous subcutaneous insulin infusion (CSII) maintain

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

PRESS RELEASE. November is Diabetes Awareness Month Severity/Epidemic and Risk Factors of Diabetes

PRESS RELEASE. November is Diabetes Awareness Month Severity/Epidemic and Risk Factors of Diabetes November 7, 2012- (Part 1 in a series of 5) November is Diabetes Awareness Month Severity/Epidemic and Risk Factors of Diabetes Data released from the American Diabetes Association have found almost 26

More information

Findings Report: Humboldt Park Community Nutrition & Physical Activity Survey

Findings Report: Humboldt Park Community Nutrition & Physical Activity Survey Findings Report: 2013 Humboldt Park Community Nutrition & Physical Activity Survey 1 Introduction In summer 2005 and again in summer 2009, with assistance from SUHI, CO-OP Humboldt Park and the Consortium

More information

Physical Activity/Exercise Prescription with Diabetes

Physical Activity/Exercise Prescription with Diabetes Physical Activity/Exercise Prescription with Diabetes B R AD H I NTERMEYER C E P A C SM S A NFORD H E ALTH C A RDIAC R E H AB A N D D I ABE TES E XE RCISE The adoption and maintenance of physical activity

More information

15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016

15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016 15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016 Sponsored by: Abbott Diabetes Care and Lilly Diabetes Type 1 and exercise Royal Berkshire Hospital Centre for Diabetes and Endocrinology

More information

Diabetes Medical Management Plan

Diabetes Medical Management Plan Date of Plan: Diabetes Medical Management Plan This plan should be completed by the student s personal health care team and parents/guardian. It should be reviewed with relevant school staff and copies

More information

Diabetes Self-Management Support: Finding the Right Balance. June 30, 2016

Diabetes Self-Management Support: Finding the Right Balance. June 30, 2016 Diabetes Self-Management Support: Finding the Right Balance June 30, 2016 Objectives n Review and discuss the intent of the 2016 American Diabetes Association (ADA) Standards of Care n Discuss how the

More information

In general: Hypoglycemia is common in insulin treated diabetes, but may also occur in people on oral medications, especially sulfonylureas/glinides.

In general: Hypoglycemia is common in insulin treated diabetes, but may also occur in people on oral medications, especially sulfonylureas/glinides. 1 2 3 In general: Hypoglycemia is common in insulin treated diabetes, but may also occur in people on oral medications, especially sulfonylureas/glinides. 4 Answer: b and c Many alcohol containing drinks

More information

Commissioning Policy Individual Funding Request

Commissioning Policy Individual Funding Request Commissioning Policy Individual Funding Request Continuous Glucose Monitors Prior Approval Policy Date Adopted: 13 October 2017 Version: 1718.2 Document Control Title of document Continuous Glucose Monitors

More information

Starting and Helping People with Type 2 Diabetes on Insulin

Starting and Helping People with Type 2 Diabetes on Insulin Starting and Helping People with Type 2 Diabetes on Insulin Elaine Cooke, BSc(Pharm), RPh, CDE Pharmacist and Certified Diabetes Educator Maple Ridge, BC Objectives After attending this session, participants

More information

Rev. date Kaiser Foundation Health Plan of Washington

Rev. date Kaiser Foundation Health Plan of Washington PE3620000-01-17 Rev. date 2014013 2017 Kaiser Foundation Health Plan of Washington Gestational diabetes Information to help you stay healthy during your pregnancy What is gestational diabetes? How gestational

More information

OneTouch Reveal Web Application. User Manual for Healthcare Professionals Instructions for Use

OneTouch Reveal Web Application. User Manual for Healthcare Professionals Instructions for Use OneTouch Reveal Web Application User Manual for Healthcare Professionals Instructions for Use Contents 2 Contents Chapter 1: Introduction...4 Product Overview...4 Intended Use...4 System Requirements...

More information

Dedicated To. Course Objectives. Diabetes What is it? 2/18/2014. Managing Diabetes in the Athletic Population. Aiden

Dedicated To. Course Objectives. Diabetes What is it? 2/18/2014. Managing Diabetes in the Athletic Population. Aiden Managing Diabetes in the Athletic Population Dedicated To Aiden Michael Prybicien, LA, ATC, CSCS, CES, PES Athletic Trainer, Passaic High School Overlook Medical Center & Adjunct Faculty, William Paterson

More information

Understanding Type 1 Diabetes. Coach Training and Education

Understanding Type 1 Diabetes. Coach Training and Education Understanding Type 1 Diabetes Coach Training and Education 1 Training and Quiz When you have completed this slide presentation, please take the quiz at the end to check your understanding of this information.

More information

Use of Continuous Glucose Monitoring in the Detection and Prevention of Hypoglycemia

Use of Continuous Glucose Monitoring in the Detection and Prevention of Hypoglycemia Journal of Diabetes Science and Technology Volume 1, Issue 1, January 2007 Diabetes Technology Society SYMPOSIUM Use of Continuous Glucose Monitoring in the Detection and Prevention of Hypoglycemia Howard

More information

Mom! You re drinking a lot lately. Are you all right? I think so. But, you re right. I seem to be thirsty all the time. And, I m tired a lot too.

Mom! You re drinking a lot lately. Are you all right? I think so. But, you re right. I seem to be thirsty all the time. And, I m tired a lot too. Mom! You re drinking a lot lately. Are you all right? I think so. But, you re right. I seem to be thirsty all the time. And, I m tired a lot too. Maybe you should see the doctor? n c Alicia went to the

More information

Management and Family Burdens Endorsed by Parents of Youth <7 Years Old With Type 1 Diabetes

Management and Family Burdens Endorsed by Parents of Youth <7 Years Old With Type 1 Diabetes 721938DSTXXX10.1177/1932296817721938Journal of Diabetes Science and TechnologyHarrington et al research-article2017 Original Article Management and Family Burdens Endorsed by Parents of Youth

More information

Physical fitness and health-related quality of life in children and adolescents with type 1 diabetes mellitus

Physical fitness and health-related quality of life in children and adolescents with type 1 diabetes mellitus SHORT THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PH.D.) Physical fitness and health-related quality of life in children and adolescents with type 1 diabetes mellitus by Andrea Lukács Supervisor: László

More information

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Auburn South Preschool.

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Auburn South Preschool. DIABETES POLICY Mandatory Quality Area 2 The content of this policy was developed for ELAA by advocacy and diabetes educators at Diabetes Australia Vic and the Royal Children s Hospital Melbourne s manager

More information

An Evaluation of the Barriers to Patient use of Glucometer Control Solutions: A Survey of Patients, Pharmacists, and Providers

An Evaluation of the Barriers to Patient use of Glucometer Control Solutions: A Survey of Patients, Pharmacists, and Providers AADE14 ANNUAL MEETING & EXHIBITION AUGUST 6-9, 2014 ORLANDO, FL An Evaluation of the Barriers to Patient use of Glucometer s: A Survey of Patients, Pharmacists, and Providers Katherine S. O Neal, Pharm.D.,

More information

Diabetes Medical Management Plan

Diabetes Medical Management Plan of Plan: School year: Diabetes Medical Management Plan This plan should be completed by the student s personal health care team and parents/guardian. It should be reviewed with relevant school staff and

More information

Iranian Journal of Diabetes and Lipid Disorders; 2011; Vol 10, pp 1-6

Iranian Journal of Diabetes and Lipid Disorders; 2011; Vol 10, pp 1-6 Iranian Journal of Diabetes and Lipid Disorders; 2011; Vol 10, pp 1-6 Evaluation of psychometric properties of the third version of the Iranian Diabetes Attitude Scale (IR-DAS-3) Mohammad Yoosef Mahjouri

More information

Diabetes: How to Train Your Staff

Diabetes: How to Train Your Staff Diabetes: How to Train Your Staff Katherine Park, RN, MSN, NCSN kpark@parkwayschools.net The purpose of this presentation is to assist school nurses during the complex process of planning with a new diabetes

More information

Insulin Pumps - External

Insulin Pumps - External Insulin Pumps - External Policy Number: Original Effective Date: MM.01.004 04/01/2011 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/20174/1/2018 Section: DME Place(s) of

More information

Early Patient and Clinician Experiences with Continuous Glucose Monitoring

Early Patient and Clinician Experiences with Continuous Glucose Monitoring Feature Article / Early Experiences with CGM Early Patient and Clinician Experiences with Continuous Glucose Monitoring David K. Bloomgarden, MD, FACE; Janine Freeman, RD, LD, CDE; and Elizabeth DeRobertis,

More information

Diabetes Care Center Box 356176 1959 N.E. Pacific St. Seattle, WA 98195 206-598-4882 120457 University of Washington Medical Center Diabetes Care Center Arabic r02/2000 Patient Education Diabetes Care

More information

Understanding and Addressing Problematic Medication Adherence

Understanding and Addressing Problematic Medication Adherence Understanding and Addressing Problematic Medication Adherence William H. Polonsky PhD, CDE November 10, 2017 whp@behavioraldiabetes.org RATES OF VERY POOR GLYCEMIC CONTROL HEDIS data from >1000 health

More information

State of California Health and Human Services Agency Department of Health Care Services

State of California Health and Human Services Agency Department of Health Care Services State of California Health and Human Services Agency Department of Health Care Services JENNIFER KENT Director EDMOND G. BROWN JR Governor DATE: N.L.: 03-0317 Index: Benefits TO: ALL COUNTY CALIFORNIA

More information

FINAL TOPLINE. Diabetes Group. Qualities That Matter: Public Perceptions of Quality in Diabetes Care, Joint Replacement and Maternity Care

FINAL TOPLINE. Diabetes Group. Qualities That Matter: Public Perceptions of Quality in Diabetes Care, Joint Replacement and Maternity Care FINAL TOPLINE Group Qualities That Matter: Public Perceptions of Quality in Care, Joint Replacement and Maternity Care National Survey of adults recently diagnosed with type 2 diabetes about their perceptions

More information

DIABETES POLICY. Mandatory Quality Area 2

DIABETES POLICY. Mandatory Quality Area 2 DIABETES POLICY Mandatory Quality Area 2 PURPOSE To ensure that enrolled children with type 1 diabetes and their families are supported, while children are being educated and cared for by the service.

More information

Exercise Prescription in Type 1 Diabetes

Exercise Prescription in Type 1 Diabetes Exercise Prescription in Type 1 Diabetes Michael Riddell, PhD Professor, Muscle Health Research Centre and School of Kinesiology & Health Science, York University Senior Scientist, LMC Diabetes & Endocrinology,

More information

NHS Leeds CCG. Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults

NHS Leeds CCG. Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults NHS Leeds CCG Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults Produced by: Jo Alldred, Medicines Effectiveness Lead, NHS Leeds CCG Dr Bryan Power, Long Term Conditions

More information

Diabetes Care 29: , 2006

Diabetes Care 29: , 2006 Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Assessing Regimen Adherence of Adolescents With Type 1 Diabetes RONALD J. IANNOTTI, PHD 1 TONJA R. NANSEL, PHD 1 STEFAN

More information

Date of Diabetes diagnosis Type I Type II. School Nurse Phone. Mother/Guardian. Address. Home phone Work Cell. Father/Guardian.

Date of Diabetes diagnosis Type I Type II. School Nurse Phone. Mother/Guardian. Address. Home phone Work Cell. Father/Guardian. Diabetes Medical Management Plan/Individualized Healthcare Plan This plan should be completed by the student s physician, personal diabetes healthcare team and parent/guardians. It should be reviewed with

More information

Parent Form DIABETES MEDICAL MANAGEMENT PLAN This form must be renewed each school year or with any change in treatment plan

Parent Form DIABETES MEDICAL MANAGEMENT PLAN This form must be renewed each school year or with any change in treatment plan Parent Form Student s PARENT CONSENT FOR We (I), the undersigned, the parent(s)/guardian(s) of the above named child, request that this Diabetes Medical Management Plan, and any modification thereto, be

More information

Exercise in the recreational and competitive athlete with type 1 diabetes- the benefits, the risks and management strategies

Exercise in the recreational and competitive athlete with type 1 diabetes- the benefits, the risks and management strategies Exercise in the recreational and competitive athlete with type 1 diabetes- the benefits, the risks and management strategies Craig E. Taplin, MD Division of Endocrinology and Diabetes Seattle Children

More information

INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION

INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION Jaiwant Rangi, MD, FACE Nov 10 th 2018 DISCLOSURES Speaker Novo Nordisk Sanofi-Aventis Boheringer Ingleheim Merck Abbvie Abbott

More information

Diabetes Medical Management Plan

Diabetes Medical Management Plan MADISON CONSOLIDATED SCHOOLS Diabetes Medical Management Plan Date of Plan: Effective Dates : The student s personal health care team and parents/guardian should complete this plan. It should be reviewed

More information

ORIGINAL ARTICLE. Use of Freestyle Libre Pro TM Flash Glucose Monitoring System in Different Clinical Situations at a Diabetes Centre

ORIGINAL ARTICLE. Use of Freestyle Libre Pro TM Flash Glucose Monitoring System in Different Clinical Situations at a Diabetes Centre 18 Journal of The Association of Physicians of India Vol. 65 August 217 ORIGINAL ARTICLE Use of Freestyle Libre Pro TM Flash itoring System in Different Clinical Situations at a Diabetes Centre Bangalore

More information

Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna. Ipoglicemie e Monitoraggio Glicemico

Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna. Ipoglicemie e Monitoraggio Glicemico Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna Ipoglicemie e Monitoraggio Glicemico Management of Hypoglycaemia.if hypoglycemia is a problem, the principles

More information

Healthcare professionals involved in care of children and young people with Type 1 Diabetes Mellitus

Healthcare professionals involved in care of children and young people with Type 1 Diabetes Mellitus Clinical Guideline A Practical Approach to the Management of Continuous Glucose Monitoring (CGM) / Real-Time Flash Glucose Scanning (FGS) in Type 1 Diabetes Mellitus in Children and Young People Under

More information

Continuous Glucose Monitoring Devices Pharmacy Policy

Continuous Glucose Monitoring Devices Pharmacy Policy Line of Business: All Line of Business Effective date: August 16, 2017 Revision date: August 16, 2017 Continuous Glucose Monitoring Devices Pharmacy Policy This policy has been developed through review

More information

Diabetes distress 7 A s model

Diabetes distress 7 A s model Diabetes and emotional health: A toolkit for health s supporting adults with type 1 or type 2 diabetes Diabetes distress 7 A s model AWARE Be AWARE that people with diabetes may experience diabetes distress

More information